Novocure Shares Gain After PANOVA-4 Shows Improved Disease Control in Metastatic Pancreatic Cancer
Novocure reported positive topline results from its Phase 2 PANOVA-4 trial testing Tumor Treating Fields (TTFields) with atezolizumab and gemcitabine/nab-paclitaxel in first-line metastatic pancreatic ductal adenocarcinoma. The study met its primary endpoint with a statistically significant improvement in disease control rate versus a historical co…